Stay updated on Prevent Early Onset AD Clinical Trial

Sign up to get notified when there's something new on the Prevent Early Onset AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prevent Early Onset AD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The screenshots show no substantive updates to study details, eligibility criteria, or locations; any differences appear to be minor formatting or layout changes rather than content changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:14:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T10:16:02.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updated page version to v3.1.0 and added an identifier/contact (844-DIANEXR with phone 342-6397); removed the previous revision v3.0.2.
    Difference
    0.0%
    Check dated 2025-09-28T03:16:21.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:37:21.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T14:57:54.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional drug information related to Alzheimer's treatments, including Lecanemab and gantenerumab. Some previous MedlinePlus topics and location details have been removed.
    Difference
    13%
    Check dated 2025-08-30T11:44:57.000Z thumbnail image

Stay in the know with updates to Prevent Early Onset AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prevent Early Onset AD Clinical Trial page.